Sponsors are turning to technology to improve efficiency and streamline workflows. While technology is having a positive impact on trials (accelerating the collection of higher quality data, for example), its introduction into clinical trial settings has resulted in unforeseen burdens on sites. In a recent article for ACRP - Association of Clinical Research Professionals, our Chief Product Officer Elisa Cascade shares findings from Advarra's 2023 Study Activation Survey Report, which revealed that a typical oncology study now uses about 22 (yes, 22!) different systems. Sites are already dealing with substantial administrative burdens, and with nearly two-thirds of respondents in Advarra’s survey reporting that the burden caused by technology is far greater than it was just five years ago, dealing with training, onboarding, and management on 22 different systems just isn't feasible. Elisa shares her insights around what we can do to navigate this challenge here: https://lnkd.in/gn7xbsBY #ClinicalResearch #ClinicalTrials #HealthcareTechnology #HealthcareInnovation
Mohammed Ali
3w
Spot on Elisa Cascade !
Clinical Trial Diversity Advocate and Proven Growth Executive
3wAs someone who spent some time working at the site-network level, I can say first hand how important this is! Sites are completely overrun with too many different technologies that do not work work together and it drives down morale and efficiencies.